Loading viewer...
earnings
Format: PDF earnings
Alcon reported fourth-quarter 2025 sales of $2.7 billion, up 9% on a reported basis and 7% constant currency, driven by new product launches including PanOptix Pro and the Unity platform. Full-year 2025 sales reached $10.3 billion with core diluted EPS of $3.07, reflecting strong execution in surgical implantables, consumables, and vision care segments despite softer market conditions.
annual_report
264 Pages
earnings
25 Pages
The Wendy's Company
Intercept Pharmaceuticals 3Q 2016 Earnings Presentation
earningsearnings
18 Pages
Intercept Pharmaceuticals